Abundance analyses revealed that the expression of IGF2BP3 was higher in AXT cells than in AX cells, which show less malignancy than the former, and contributed to activating tumors and promoting tumor cell growth in vivo and in vitro. This evidence concerns the gene IGF2BP3 and neoplasm.